Allschwil, Basel-Landschaft, Switzerland BaseLaunch appeared to be the VC, which was created in 2017. The fund was located in Europe if to be more exact in Switzerland. The main department of described VC is located in the Allschwil.
Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2018.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland. Among the most popular portfolio startups of the fund, we may highlight POLYNEURON. Among the most popular fund investment industries, there are Medical, Medical Device.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the BaseLaunch, startups are often financed by Zu00fcrcher Kantonal Bank, Neuromuscular Research Association Basel, Gebert Ru00fcf Stiftung. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, Sofinnova Partners, New Enterprise Associates.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
NXI Therapeutics | $3M | 18 Jun 2024 | Basel, Basel-Stadt, Switzerland | ||
Engimmune Therapeutics | $545K | 21 Feb 2022 | Basel, Basel-Stadt, Switzerland | ||
Aukera Therapeutics | $545K | 15 Feb 2022 | Basel, Basel-Stadt, Switzerland | ||
Stromal Therapeutics | $545K | 28 Jan 2022 | Basel, Basel-Stadt, Switzerland | ||
PharmaBiome | 21 Jan 2020 | Zurich, Zurich, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
NXI Therapeutics | $3M | 18 Jun 2024 | Basel, Basel-Stadt, Switzerland | ||
Engimmune Therapeutics | $545K | 21 Feb 2022 | Basel, Basel-Stadt, Switzerland | ||
Aukera Therapeutics | $545K | 15 Feb 2022 | Basel, Basel-Stadt, Switzerland | ||
Stromal Therapeutics | $545K | 28 Jan 2022 | Basel, Basel-Stadt, Switzerland | ||
PharmaBiome | 21 Jan 2020 | Zurich, Zurich, Switzerland |
